AXPH Statistics

Total Valuation

Alexandria Co. For Pharmaceuticals & Chemical Industries has a market cap or net worth of EGP 1.50 billion. The enterprise value is 1.35 billion.

Market Cap	1.50B
Enterprise Value	1.35B

Important Dates

The last earnings date was Wednesday, November 20, 2024.

Earnings Date	Nov 20, 2024
Ex-Dividend Date	Nov 18, 2024

Share Statistics

Alexandria Co. For Pharmaceuticals & Chemical Industries has 5.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	5.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.68%
Owned by Institutions (%)	n/a
Float	943,424

Valuation Ratios

The trailing PE ratio is 6.92.

PE Ratio	6.92
Forward PE	n/a
PS Ratio	0.85
PB Ratio	1.89
P/TBV Ratio	1.89
P/FCF Ratio	11.77
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.43, with an EV/FCF ratio of 10.60.

EV / Earnings	6.23
EV / Sales	0.76
EV / EBITDA	4.43
EV / EBIT	5.05
EV / FCF	10.60

Financial Position

The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.00.

Current Ratio	1.97
Quick Ratio	0.69
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 29.78% and return on invested capital (ROIC) is 22.78%.

Return on Equity (ROE)	29.78%
Return on Assets (ROA)	15.45%
Return on Capital (ROIC)	22.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.63
Inventory Turnover	3.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+65.18%
50-Day Moving Average	275.03
200-Day Moving Average	236.86
Relative Strength Index (RSI)	58.56
Average Volume (20 Days)	1,624

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of EGP 1.77 billion and earned 216.68 million in profits. Earnings per share was 43.34.

Revenue	1.77B
Gross Profit	395.18M
Operating Income	267.49M
Pretax Income	282.03M
Net Income	216.68M
EBITDA	305.05M
EBIT	267.49M
Earnings Per Share (EPS)	43.34

Full Income Statement

Balance Sheet

The company has 150.04 million in cash and 813,066 in debt, giving a net cash position of 149.22 million or 29.84 per share.

Cash & Cash Equivalents	150.04M
Total Debt	813,066
Net Cash	149.22M
Net Cash Per Share	29.84
Equity (Book Value)	794.98M
Book Value Per Share	159.00
Working Capital	422.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 189.62 million and capital expenditures -62.22 million, giving a free cash flow of 127.41 million.

Operating Cash Flow	189.62M
Capital Expenditures	-62.22M
Free Cash Flow	127.41M
FCF Per Share	25.48

Full Cash Flow Statement

Margins

Gross margin is 22.35%, with operating and profit margins of 15.13% and 12.26%.

Gross Margin	22.35%
Operating Margin	15.13%
Pretax Margin	15.95%
Profit Margin	12.26%
EBITDA Margin	17.25%
EBIT Margin	15.13%
FCF Margin	7.21%

Dividends & Yields

This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 10.00%.

Dividend Per Share	30.00
Dividend Yield	10.00%
Dividend Growth (YoY)	130.77%
Years of Dividend Growth	2
Payout Ratio	37.83%
Buyback Yield	n/a
Shareholder Yield	10.00%
Earnings Yield	14.45%
FCF Yield	8.49%

Dividend Details

Stock Splits

The last stock split was on December 11, 2014. It was a forward split with a ratio of 1.11111111.

Last Split Date	Dec 11, 2014
Split Type	Forward
Split Ratio	1.11111111

Scores

Alexandria Co. For Pharmaceuticals & Chemical Industries has an Altman Z-Score of 4.63.

Altman Z-Score	4.63
Piotroski F-Score	n/a